(Q44932061)

English

Anti-apoptotic effect of atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardiac myocytes through protein kinase C activation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Anti-apoptotic effect of atorvastatin, a 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitor, on cardiac myocytes through protein kinase C activation (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

apoptotic process

0 references

1

object named as

Koichi Tanaka

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

Masaaki Honda

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Toshikazu Takabatake

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

publication date

1 May 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Clinical and Experimental Pharmacology and Physiology

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

31

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

5-6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

360-364

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2004.04010.X

21 January 2018

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2004.04010.X

21 January 2018

Stimulation of bone formation in vitro and in rodents by statins

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2004.04010.X

21 January 2018

The HMG-CoA reductase inhibitor simvastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2004.04010.X

21 January 2018

Limitation of myocardial infarct size by adenosine A1 receptor activation is abolished by protein kinase C inhibitors in the rabbit

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2004.04010.X

21 January 2018

Staurosporine-induced apoptosis in cardiomyocytes: A potential role of caspase-3.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2004.04010.X

21 January 2018

Chelerythrine rapidly induces apoptosis through generation of reactive oxygen species in cardiac myocytes.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2004.04010.X

21 January 2018

A selective epsilon-protein kinase C antagonist inhibits protection of cardiac myocytes from hypoxia-induced cell death

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2004.04010.X

21 January 2018

Adenosine A1 stimulation activates delta-protein kinase C in rat ventricular myocytes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2004.04010.X

21 January 2018

Redox regulation of MAPK pathways and cardiac hypertrophy in adult rat cardiac myocyte

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2004.04010.X

21 January 2018

Levels of soluble cell adhesion molecules in patients with dyslipidemia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2004.04010.X

21 January 2018

Myocardial K(ATP) channels in preconditioning

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2004.04010.X

21 January 2018

Fluvastatin induces apoptosis in rat neonatal cardiac myocytes: a possible mechanism of statin-attenuated cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2004.04010.X

21 January 2018

Effect of atorvastatin and fluvastatin on the expression of plasminogen activator inhibitor type-1 in cultured human endothelial cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1681.2004.04010.X

21 January 2018

Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.2004.04010.X

Long-term effectiveness and safety of pravastatin in 9014 patients with coronary heart disease and average cholesterol concentrations: the LIPID trial follow-up

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.2004.04010.X

Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.2004.04010.X

Atorvastatin but not L-arginine improves endothelial function in type I diabetes mellitus: a double-blind study

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.2004.04010.X

Apoptosis in myocytes in end-stage heart failure

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.2004.04010.X

3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase and Isoprenylation Inhibitors Induce Apoptosis of Vascular Smooth Muscle Cells in Culture

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.2004.04010.X

Statin-induced apoptosis of vascular endothelial cells is blocked by dexamethasone.

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.2004.04010.X

Pretreatment with PKC activator protects cardiomyocytes against reoxygenation-induced hypercontracture independently of Ca2+ overload

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.2004.04010.X

Hyperlipidemia and coronary disease. Correction of the increased thrombogenic potential with cholesterol reduction

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.2004.04010.X

HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis

1 reference

11 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1111/J.1440-1681.2004.04010.X

Identifiers

10.1111/J.1440-1681.2004.04010.X

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44932061&oldid=2057990135"